Meet our Portfolio Companies
Antiverse
Combining AI and wet lab biology to design de novo antibodies for challenging GPCR targets implicated in cancer and immune diseases.
Dyania Health
Natural language processing for complex, unstructured medical data to accelerate patient matching to clinical trials and enable real world data research.
Javelin Biotech
Microphysiological systems combining organs-on-chips, multi-omic analysis, and AI-driven modeling to accelerate drug discovery and development.
Arrepath
Anti-infective discovery platform coupling cell imaging with machine learning analysis to identify new drug candidates and new mechanisms of action.
Encora
Wearable device delivering AI-informed vibrational neurostimulation to sense & reduce tremors in real time for Parkinson’s & Essential Tremor patients.
Odaia Intelligence
AI-driven SaaS platform creating more targeted, impactful engagement between healthcare providers and pharma sales teams.
BioIntelligence
Improving biomanufacturing across several domains by enabling advanced process control of high-variation fermentation processes, therefore generating better yields.
Ilios Therapeutics
A biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases.
Olaris Therapeutics
Precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.
Path.AI
AI-driven pathology analysis enabling research and assisting pathologists in making rapid and accurate diagnoses for every patient, every time.
ViaScientfic
Enabling biologists to perform routine bioinformatics analysis independently, without the need to consult bioinformaticians.
Persist.AI
ML-powered platform that predicts extended-release formulations for any drug, enabling generics manufacturers to get XR formulations to market.
Zeta Surgical
Computer vision for bedside image-based navigation in minimally invasive surgery, enabling new treatments in neurological surgery and beyond.
STRM.bio
Leveraging AI and extracellular vesicles (EVs) to deliver gene therapy in a simpler, safer, and more practical way.